A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
Clinical trial NCT05824455 · TERMINATED
Trial details
- NCT number
- NCT05824455
- Sponsor
- Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2023-09-28
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.